Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)

Cephalon Investigational Site, Brussels

Cephalon Investigational Site, Brussels

Monter Cancer Center, Lake Success

Roswell Park Cancer Institute, Buffalo

University of Pittsburgh Medical Center - Cancer Institute, Pittsburgh

Carroll County Cancer Center, Westminster

Fairfax/Northern Virginia Hematology/Oncology, Fairfax

Cephalon Investigational Site, Nahariya

Cancer Centers of the Carolinas, Greenville

Northwest Georgia Oncology Center, Marietta

Georgia Cancer Specialists, Tucker

Dublin Hematology Oncology Care P.C., Dublin

Cephalon Investigational Site, Haifa

University Cancer Institute, Boynton Beach

Florida Cancer Institute - New Hope, New Port Richey

Birmingham Hematology and Oncology Associates, LLC, Birmingham

The West Clinic, Memphis

Kentucky Cancer Clinic, Hazard

Siouxland Hematology-Oncology Assoc. LLP, Sioux City

Mid Dakota Clinic, Bismarck

Cancer Care and Hematology Specialists of Chicagoland, Niles

Columbia Comprehensive Cancer Care Clinic, Jefferson City

Longview Cancer Center, Longview

Texas Oncology, P.A., Bedford

US Oncology Research - Texoma Cancer Center, Wichita Falls

Texas Oncology, Waco

Texas Oncology, P.A., Webster

Cancer Care Centers of South Texas, San Antonio

Texas Oncology, P.A., McAllen

Joe Arrington Cancer Research, Lubbock

Nevada Cancer Institute, Las Vegas

Oregon Health Sciences University, Portland

Yakima Valley Memorial Hospital/North Start Lodge, Yakima

University of Alabama at Birmingham, Birmingham

Tower Cancer Research Foundation, Beverly Hills

Hematology Oncology, P.C., Stamford

Somerset Hematology Oncology Associates, Somerville

MD Anderson Cancer Center, Houston

Cephalon Investigational Site, Ghent